TOP STORIES

• BUSINESS Drug Makers Concerned about Cost-Effective Assessments Used for NHI Price Cuts: Survey
  November 28, 2016

• REGULATORY Keytruda Clears MHLW Panel for Both 1st-Line, 2nd-Line NSCLC
  November 25, 2016

• BUSINESS 27 Japan Drug Makers Eke Out Profit despite Logging Lower Sales on FX, Price Cuts: Jiho Tally
  November 24, 2016

• REGULATORY MHLW to Announce Opdivo’s New Prices on Nov. 24
  November 24, 2016

• BUSINESS Taltz Finally Makes it to Japan Market after Pricing Flap
  November 22, 2016

• BUSINESS 3 Japan Generic Majors See Subdued Sales Rise in April-September
  November 21, 2016

• REGULATORY MHLW to Kick Off Discussions for Major Drug Pricing Overhaul by Year-End: Bureau Chief
  November 18, 2016

• REGULATORY 50% Price Cut for Opdivo OK’ed with Estimated Sales of 151.6-Plus Billion Yen
  November 17, 2016

• REGULATORY ICH Eyes Major GCP Revamp with Use of Real World Data: Osaka Confab
  November 16, 2016

• REGULATORY Opdivo’s NHI Price-Based Sales Put at Over 151 Billion Yen; 50% Cut Likely to Take Effect Feb. 1
  November 15, 2016

• TRENDS AGs Set to Break into 10 Billion Yen Territory in Japan
  November 14, 2016

• REGULATORY MHLW Panel to Discuss NSCLC Indication for Keytruda on Nov. 24
  November 14, 2016

• REGULATORY LDP Study Group on Biologics to Hold 1st Meeting on Nov. 24; Aims to Halt the Rush to Promote Biosimilars
  November 11, 2016

• BUSINESS Top 4 Wholesalers See Lower Sales in April-September If Hep C Meds Excluded
  November 11, 2016

• REGULATORY MHLW Plans 50% Price Cut for Opdivo
  November 10, 2016

• REGULATORY Chuikyo OKs Taltz, Micatrio for Listing on Nov. 18; Keytruda Takes Pass This Time
  November 9, 2016

• BUSINESS Current Drug Pricing System Became Unfit for New Drugs Like Opdivo: Ono Chief
  November 8, 2016

• BUSINESS MSD’s New Dual Oral Hep C Therapy to Challenge Harvoni; Effective Regardless of Resistance Mutations, Renal Impairment
  November 8, 2016

• ACADEMIA Draft Guidelines on Pneumonia Treatment Set Guides for Selecting Antibacterial Agents: Respiratory Society
  November 7, 2016

• REGULATORY PMDA Mulls Fee Raise for Drug, Device Reviews
  November 4, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 163
• 164
• 165
• 166
• 167
• 168
• 169
• 170
• 171
• …
• Next ›
• 最終 »